IP Library Granted Patent US 7,856,985
Granted Patent B2
US 7,856,985 · App. 11/347,672 · Granted Dec 28, 2010

Method of treatment body tissue using a non-uniform laser beam

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,856,985
App. No.
11/347,672
Granted
Dec 28, 2010
Kind
B2
Abstract

Methods and apparatus for treatment, such as skin rejuvenation treatment, using non-uniform laser radiation. A high-intensity portion of the laser radiation causes collagen destruction and shrinkage within select portions of the treatment area, while a lower-intensity portion of the radiation causes fibroblast stimulation leading to collagen production across other portions of the treatment area. An output beam from a laser source, such as an Nd:YAG laser, is coupled into an optical system that modifies the beam to provide a large-diameter beam having a non-uniform energy profile, comprised of a plurality of high-intensity zones surrounded by lower-intensity zones within the treatment beam. The higher-intensity zones heat select portions of the target tissue to temperatures sufficient for a first treatment (e.g. collagen shrinkage), while the lower-intensity zones provide sufficient energy for a second treatment (e.g. stimulated collagen production). A large area of tissue, preferably 7-10 mm in diameter, can be treated simultaneously, while minimizing the risk of burning or other damage to the skin. In one embodiment, the invention uses a fiber bundle to provide a non-uniform energy output beam. In another embodiment, the invention uses a diffractive lens array to produce the non-uniform output beam. A cooling system can also be integrated with the laser treatment system.

Claims (22)

1. A method of treating human tissue, comprising:

generating an output beam from a laser source; coupling the beam into an optical system that modifies the beam to provide a treatment beam having a non-uniform energy profile, said non-uniform energy profile being comprised of regions of relatively high energy per unit area within a substantially uniform background region of relatively low energy per unit area in comparison to the regions of relatively high energy per unit area; and

directing the treatment beam to a target tissue area such that the regions of relatively high energy per unit area deliver sufficient energy to target tissue to beat select portions of the target tissue to a first temperature to shrink collagen and wherein the substantially uniform background region of relatively low energy per unit area delivers sufficient energy to target tissue to stimulate collagen production in the remaining portion of the target tissue.

2. The method of claim 1 , wherein the treatment beam at the regions of relatively high energy per unit area heats select portions of the target tissue to a temperature of 70°C. or higher.

3. The method of claim 1 , wherein the laser source comprises an Nd:YAG laser.

4. The method of claim 1 , wherein the wavelength of the output beam is between about 1.3 microns and 1.6 microns.

5. The method of claim 1 , wherein the wavelength of the output beam is between about 1.40 and 1.44 microns.

6. The method of claim 1 , wherein the treatment beam at the target tissue area has a diameter between about 7 and 10 mm., and wherein the average fluence of the treatment beam at the target tissue area is less than about 10 J/cm 2 .

7. The method of claim 1 , wherein the output beam has a pulse duration of between 0.1 and 100 milliseconds.

8. The method of claim 7 , wherein the output beam has a pulse duration of between 1 and 5 milliseconds.

9. The method of claim 1 , wherein the optical system comprises a fiber bundle.

10. The method of claim 9 , wherein the fiber bundle comprises between about 1000 and about 2000 fibers.

11. The method of claim 10 , wherein the optical system comprises focusing lens for coupling the output beam into a proximal end of the fiber bundle, and an optical window between the distal end of the fiber bundle and the target tissue, the optical window permitting the beam emitted from each fiber in the bundle to diverge before it reaches the target skin so that each beam partially overlaps with the beam(s) from adjacent fibers in the bundle.

12. The method of claim 11 , wherein the optical window is between 1 and 5 mm thick.

13. The method of claim 1 , wherein the optical system comprises a diffractive lens array arranged in an optical path between a laser source and the treatment area, such that each lens in the array provides a high-intensity zone surrounded by a low intensity zone of radiation.

14. The method of claim 13 , wherein the diffractive lens array comprises between about 100 and about 2000 lenses in the array.

15. The method of claim 14 , wherein each lens is between about 150 and 1000 microns in diameter.

16. The method of claim 13 , wherein the diffractive lens array is between 7 and 10 millimeters in diameter.

17. The method of claim 1 , wherein the ratio of peak energy per unit area in the regions of relatively high energy per unit area to the average energy per unit area in the background region is greater than 4.5 to 1.

18. The method of claim 1 , wherein the ratio of the average energy per unit area in the regions of relatively high energy per unit area to the average energy per unit area in the background region is greater than 10 to 1.

19. The method of claim 1 , wherein the ratio of average energy per unit area in the regions of relatively high energy per unit area to the average energy per unit area in the background region is greater than 50 to 1.

20. The method of claim 1 , wherein the ratio of average energy per unit area in the regions of relatively high energy per unit area to the average energy per unit area in the background region is greater than 100 to 1.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Mar 1, 2024
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
To: CYNOSURE, LLC; PALOMAR MEDICAL TECHNOLOGIES, LLC
Reel/Frame 066723/0227 →
TERMINATION AND RELEASE OF PATENTS Recorded Feb 29, 2024
From: UBS AG, STAMFORD BRANCH, AS COLLATERAL AGENT
To: CYNOSURE, LLC; PALOMAR MEDICAL TECHNOLOGIES, LLC
Reel/Frame 066707/0957 →
ABL NOTICE AND CONFIRMATION OF GRANT OFSECURITY INTEREST IN PATENTS Recorded Jan 12, 2024
From: CYNOSURE, LLC; PALOMAR MEDICAL TECHNOLOGIES, LLC
To: UBS AG, STAMFORD BRANCH, AS COLLATERAL AGENT
Reel/Frame 066222/0937 →
NOTICE AND CONFIRMATION OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Jan 7, 2020
From: CYNOSURE, LLC; PALOMAR MEDICAL TECHNOLOGIES, LLC
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 051496/0579 →
RELEASE OF SECURITY INTEREST IN PATENT RIGHTS Recorded Dec 30, 2019
From: BANK OF AMERICA, N.A.
To: CYNOSURE, LLC
Reel/Frame 051447/0536 →
SECURITY INTEREST Recorded Oct 14, 2019
From: HOLOGIC, INC.; CYNOSURE, LLC; CYTYC CORPORATION; FAXITRON BIOPTICS, LLC; FOCAL THERAPEUTICS, INC.; GEN-PROBE INCORPORATED
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 050719/0701 →
CHANGE OF NAME Recorded Mar 22, 2019
From: CYNOSURE, INC.
To: CYNOSURE, LLC
Reel/Frame 048678/0928 →
SECURITY INTEREST Recorded May 3, 2017
From: CYNOSURE, INC.; PALOMAR MEDICAL TECHNOLOGIES, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 042261/0911 →